Multiple Wall Street analysts issued upgrades on individual stocks across healthcare, industrials, materials, and other sectors on July 28, 2026.
Broad-based analyst upgrade activity across healthcare, industrials, and materials sectors can reflect shifting sentiment on sector-specific fundamentals; for EW (Edwards Lifesciences), which operates in the medtech/healthcare space, analyst valuation revisions in adjacent healthcare names may signal broader reassessment of the sector's risk-reward profile, affecting relative positioning among healthcare equities.